ABSTRACT NUMBER: ESOC2026A1311 BRIDGING THERAPY VERSUS DIRECT THROMBECTOMY IN CARDIOEMBOLIC ACUTE ISCHEMIC STROKE PATIENTS WITH MIDDLE CEREBRAL ARTERY OCCLUSION
Changgeng Fang, Ximing Nie, Yuesong Pan, Liping Liu · 2026
Read ABSTRACT NUMBER: ESOC2026A1311 BRIDGING THERAPY VERSUS DIRECT THROMBECTOMY IN CARDIOEMBOLIC ACUTE ISCHEMIC STROKE PATIENTS WITH MIDDLE CEREBRAL ARTERY OCCLUSION by Changgeng Fang, Ximing Nie, Yuesong Pan, Liping Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13145913.txt.
Description
Changgeng Fang, Ximing Nie, Yuesong Pan, and Liping Liu compare two clot treatment paths for a kind of stroke in this 2026 conference abstract. The strokes were cardioembolic, caused by clots from the heart, blocking the middle cerebral artery. One path gives a clot busting drug first, then a catheter procedure to pull the clot, called bridging therapy. The other goes straight to the catheter. The team gathered cases from many centers, where patients arrived within twenty-four hours of onset.
The study enrolled 691 patients, then matched the groups one to one, leaving 422 for analysis. Functional recovery at ninety days was near equal under both paths. Early decline also matched. Death at ninety days, though, was far lower with bridging therapy, at about eighteen percent against thirty-four. The authors conclude the drug first path costs nothing in recovery and may save lives in this stroke type.
Catalog record
| CREATOR | Changgeng Fang, Ximing Nie, Yuesong Pan, Liping Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |